...
首页> 外文期刊>Leukemia and lymphoma >Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease
【24h】

Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease

机译:新型地幔细胞淋巴瘤细胞系PF-1的发展过程中涉及肿瘤相关巨噬细胞的活化,该细胞系来自典型的复发性疾病患者

获取原文
获取原文并翻译 | 示例
           

摘要

Human mantle cell lymphoma (MCL) cell lines are scarce and have been only sporadically described and validated, and only a few have been thoroughly molecularly or genetically characterized. We describe here the successful establishment of a new MCL line, PF-1, with typical MCL characteristics. Culturing primary MCL cells in vitro initially gave rise to an essential generative microenvironment "niche" involving macrophages required for MCL growth, and eventually produced the PF-1 MCL cell line. Our analysis revealed that PF-1 is morphologically and genotypically nearly identical to the original tumor cells. The PF-1 MCL cell line that we have developed will be useful for in vitro and in vivo studies of MCL pathogenesis and therapeutics.
机译:人套细胞淋巴瘤(MCL)细胞系十分稀少,仅在零星地进行了描述和验证,并且只有少数经过彻底的分子或遗传学表征。我们在这里描述成功建立具有典型MCL特性的新MCL线PF-1。体外培养原代MCL细胞最初会产生一个必需的生成性微环境“利基”,其中涉及MCL生长所需的巨噬细胞,最终产生了PF-1 MCL细胞系。我们的分析表明,PF-1在形态和基因型上与原始肿瘤细胞几乎相同。我们开发的PF-1 MCL细胞系将可用于MCL发病机理和治疗方法的体外和体内研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号